معرفی
Prof. Dr. Ralph Holl is a Professor of Medical Chemistry at the University of Hamburg, where he leads the AG Holl research group at the Institute of Organic Chemistry within the Department of Chemistry of the Faculty of Mathematics, Informatics and Natural Sciences.
His educational background includes:
- Habilitation and venia legendi for Pharmaceutical and Medical Chemistry, University of Münster (2016)
- PhD (Dr. rer. nat.) in Pharmaceutical and Medical Chemistry, University of Münster (2008)
- Pharmacy degree (Apotheker), University of Freiburg (2004)
Prof. Holl's research focuses on the development of novel antibiotics and enzyme inhibitors. His work centers on the design and synthesis of inhibitors targeting bacterial enzymes, particularly LpxC, which is essential for lipid A biosynthesis in Gram-negative bacteria. He also investigates inhibitors of zinc-dependent enzymes including histone deacetylases (HDACs) and matrix metalloproteinases (MMPs). His laboratory employs stereoselective synthesis techniques and specializes in the creation of C-glycosides and other carbohydrate-based compounds for medicinal applications. The group utilizes molecular docking studies to guide rational drug design and optimize structure-activity relationships.
Analysis of Prof. Holl's recent publications reveals a consistent focus on LpxC inhibitors as potential antibiotics, with increasing sophistication in molecular design. His work spans fragment-based approaches, structure-activity relationship studies, and the development of novel scaffolds including pyrrolidine derivatives. There's a clear progression from basic inhibitor design to more complex multi-target approaches, with recent work exploring triazole-based compounds and fragment-based inhibitors with improved potency.
His scientific achievements have been recognized with prestigious awards:
- Rottendorf-Preis für Pharmazie (2013)
- Klaus Grohe-Preis für Medizinische Chemie (2011)
Prof. Holl has supervised numerous Bachelor's, Master's, and doctoral students through their research projects, contributing significantly to the education of next-generation medicinal chemists. His research group maintains active collaborations with other institutions and researchers in the field of antibiotic development and enzyme inhibition.
The AG Holl research group operates within the Institute of Organic Chemistry at the University of Hamburg, utilizing state-of-the-art facilities for organic synthesis, biological testing, and computational modeling to advance their work on novel therapeutic agents.
